compounded tirzepatide is no longer available nationwide Troubling Findings in Study of GLP-1 Compounders The Impact of New FDA

Romero-Gmez M, Lawitz E, Shankar RR, Chaudhri E, Liu J, Lam RLH, et al

The FDA has proposed permanently excluding tirzepatide (along with semaglutide and liraglutide) from large-scale 503B compounding, and on June 26, 2026 it extended the public comment deadline on that proposal from June 30 to July 30, 2026

PlexusDx compounded tirzepatide injections (at $289/mo month-to-month, or from $249/mo on the 6-month plan) are adjusted flexibly based on your kidney function, clinical response, and genetic peptide markers

Larsen for expert technical assistance with conducting the animal studies

First, using HPLC and HPLC-associated radioactive detector, we identified six radioactive components, in addition to prototype [ 3 H]BPC157, in rat plasma collected at 0.05, 0.167, 1, 8, and 24 h after administration (Supplementary Figure S1)